Cognex (NASDAQ:CGNX) Releases FY 2026 Earnings Guidance

Cognex (NASDAQ:CGNX) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 1.640-1.680 for the period, compared to the consensus estimate of 1.480. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.1 billion. Cognex also updated its Q3 2026 guidance to 0.500-0.540 EPS.

Cognex Stock Performance

NASDAQ CGNX traded down $3.33 during trading hours on Thursday, hitting $67.38. 3,899,578 shares of the company traded hands, compared to its average volume of 2,212,210. The stock has a market capitalization of $11.21 billion, a price-to-earnings ratio of 80.21 and a beta of 1.49. Cognex has a twelve month low of $34.60 and a twelve month high of $72.88. The business’s 50-day moving average is $64.96 and its 200-day moving average is $56.90.

Cognex (NASDAQ:CGNX) last released its quarterly earnings data on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.42 by $0.03. The company had revenue of $291.26 million during the quarter, compared to the consensus estimate of $292.10 million. Cognex had a return on equity of 10.89% and a net margin of 13.62%.The firm’s revenue for the quarter was up 16.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.25 EPS. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. Analysts predict that Cognex will post 1.48 EPS for the current year.

Cognex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Thursday, August 20th will be issued a $0.085 dividend. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Thursday, August 20th. Cognex’s dividend payout ratio is presently 40.48%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on CGNX shares. Seaport Research Partners set a $75.00 price target on Cognex in a report on Tuesday, May 26th. Sanford C. Bernstein restated an “outperform” rating and set a $75.00 target price on shares of Cognex in a research note on Thursday, May 7th. Stephens increased their price target on shares of Cognex from $65.00 to $75.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Truist Financial boosted their price objective on Cognex from $61.00 to $71.00 and gave the stock a “hold” rating in a report on Thursday, July 2nd. Finally, Robert W. Baird set a $72.00 target price on Cognex in a research note on Friday, May 8th. Two analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $72.31.

Insiders Place Their Bets

In other Cognex news, VP Laura Ann Macdonald sold 98,122 shares of Cognex stock in a transaction on Monday, May 11th. The stock was sold at an average price of $66.80, for a total value of $6,554,549.60. Following the completion of the transaction, the vice president directly owned 5,258 shares of the company’s stock, valued at $351,234.40. The trade was a 94.91% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Darren Marc Long sold 20,252 shares of the stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total value of $1,343,517.68. Following the sale, the vice president directly owned 3,990 shares in the company, valued at approximately $264,696.60. This trade represents a 83.54% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 224,847 shares of company stock worth $14,975,098 in the last quarter. Corporate insiders own 1.70% of the company’s stock.

Key Stories Impacting Cognex

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Earnings and outlook exceeded expectations: Cognex reported second-quarter EPS of $0.45, above the $0.42 consensus and up from $0.25 a year earlier. Management also issued third-quarter EPS guidance of $0.50–$0.54, well above the $0.37 analyst estimate, and raised full-year 2026 EPS guidance to $1.64–$1.68. Cognex Q2 Earnings Beat on Margin Gains Despite Revenue Miss
• Positive Sentiment: Strong operating performance: Second-quarter revenue reached a record $291 million, up approximately 17% year over year, while net income increased to $72.8 million from $40.5 million. Margin improvement, favorable product mix and cost controls supported the earnings beat. Cognex Reports Second Quarter 2026 Results
• Positive Sentiment: Growth expectations remain favorable: Cognex forecast third-quarter revenue of $300 million–$320 million and full-year 2026 revenue of approximately $1.13 billion–$1.15 billion, with growth attributed to broad strength across major end markets.
• Neutral Sentiment: Dividend declared: The company announced a quarterly cash dividend of $0.085 per share, payable September 3 to shareholders of record on August 20. The roughly 0.5% yield is modest and is unlikely to be a major stock catalyst. Cognex Delivers Record Q2 Results and Raises Dividend
• Negative Sentiment: Revenue missed estimates: Quarterly revenue of about $291 million fell slightly short of the $292.1 million consensus. This miss appears to be outweighing the EPS beat and upbeat guidance in near-term trading.
• Negative Sentiment: Valuation and insider selling could add pressure: Cognex trades at a high earnings multiple, while reported insider activity showed sales and no purchases during the past six months. These factors may make investors less tolerant of even a small revenue miss.

Hedge Funds Weigh In On Cognex

Several hedge funds have recently bought and sold shares of the company. CIBC Private Wealth Group LLC raised its position in Cognex by 74.8% during the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock valued at $35,000 after purchasing an additional 327 shares in the last quarter. Geneos Wealth Management Inc. increased its stake in shares of Cognex by 402.2% in the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after purchasing an additional 736 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new position in shares of Cognex during the 4th quarter worth $39,000. Wexford Capital LP bought a new stake in shares of Cognex during the 3rd quarter worth $52,000. Finally, Meeder Asset Management Inc. acquired a new stake in Cognex in the fourth quarter valued at about $47,000. 88.12% of the stock is owned by institutional investors.

About Cognex

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.